Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%

Cameron to Announce Plan for World-First Phenome-Research Center

U.K. Prime Minister David Cameron will announce plans to transform the London Olympic anti-doping facility into a 10 million-pound ($16 million) center that studies how genes are transformed by lifestyle.

The phenome center in Harlow, northeast of London, will allow scientists to study how people respond to drugs and allow them to investigate the effects of diet, the environment and stress on the molecular make-up of individuals to develop new treatments. Cameron will announce the project, the first of its kind in the world, at a gathering of health professionals in London today.

“This will take advantage of the extraordinary opportunities that lie in combining genetic data with the results of medical tests on tissues and blood,” Cameron will say, according to remarks released by his office. “It will produce new forms of drugs and it will lead the world in the development of precision medicine.”

Facilities and equipment for the center are being provided by GlaxoSmithKline Plc (GSK), to which Bruker Corp. (BRKR) and Waters Corp. will also contribute.

To contact the reporter on this story: Gonzalo Vina in London at gvina@bloomberg.net

To contact the editor responsible for this story: James Hertling at jhertling@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.

Sponsored Link